Ben Carson steps down from Vaccinogen board to focus on presidential campaign

Ben Carson became a candidate for President this week. With the decision to seek the Republican nomination, the retired Johns Hopkins surgeon gave up a seat on the board of a Baltimore-based biotech company.

On Tuesday, Carson resigned as chairman of the board of Vaccinogen, a company working to make a vaccine that would keep colon cancer from recurring after surgery. The company relocated from Frederick to a new headquarters in Fells Point earlier this year.
“I continue to believe Vaccinogen’s patient-specific cancer vaccine platform truly has the potential to revolutionize cancer treatment and serve the greater good,” Carson said in a statement. “Despite my passion for this extremely important innovation, I now must focus my full attention on my campaign and serving the American people.”
Carson will be replaced on the board by Vaccinogen CEO Andrew L. Tussing, who will serve as chairman.